FORA Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
13,332
-1,885
-12% -$205K 0.14% 166
2026
Q1
$1.41M Buy
15,217
+7,628
+101% +$766K 0.1% 200
2025
Q4
$775K Buy
+7,589
New +$679K 0.09% 244
2025
Q2
Sell
-11,077
Closed -$472K 576
2025
Q1
$472K Buy
+11,077
New +$478K 0.05% 330
2021
Q1
Sell
-13,691
Closed -$1.76M 888
2020
Q4
$1.76M Buy
13,691
+9,164
+202% +$1.05M 0.27% 85
2020
Q3
$506K Buy
4,527
+4,158
+1,127% +$380K 0.33% 61
2020
Q2
$30K Buy
+369
New +$29.7K 0.01% 742

Other funds holding GH

FORA Capital's GH Position: Q2 2026 in Review

FORA Capital reduced its Guardant Health (GH) stake by 12% in Q2 2026, selling an estimated $205K and leaving 13,332 shares worth $2M. The position accounts for 0.14% of the portfolio, ranked #166.

FORA Capital first reported a position in GH in Q2 2020 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • FORA Capital held 13,332 shares of Guardant Health worth $2M as of Q2 2026.
  • FORA Capital sold 1,885 Guardant Health shares in Q2 2026, an estimated $205K.
  • Guardant Health made up 0.14% of FORA Capital's portfolio in Q2 2026, its #166 holding.
  • FORA Capital first reported a position in Guardant Health in Q2 2020 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.